IN BRIEF: Indivior names former Collegium Pharmaceutical chief as CEO

Related news

Indivior PLC - Richmond, Virginia-based maker of medicines to treat substance use - Appoints Non-Executive Director Joe Ciaffoni as chief executive officer, replacing Mark Crossley. The handover is expected to be after Indivior’s annual general meeting in May. Indivior says Crossley is stepping down ‘by mutual agreement’ and ‘following a distinguished tenure’ as CEO since 2020. Crossley joined the board in December. Most recently, he was CEO of Nasdaq-listed Collegium Pharmaceutical Inc.

Current stock price: 669.00 pence, up 2.8% in London on Thursday

12-month change: down 61%

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Directors

Ways to help you invest your money

Our investment accounts

Put your money to work with our range of investment accounts. Choose from ISAs, pensions, and more.

Need some investment ideas?

Let us give you a hand choosing investments. From managed funds to favourite picks, we’re here to help.

Read our expert tips and insights

Our investment experts share their knowledge on how to keep your money working hard across the markets.